# Pennant Group, Inc.: financial statements, quarterly

PNTG · Nasdaq · CIK 1766400 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pntg.md) · [Financials](/companies/pntg/financials.md) · [Filings](/companies/pntg/filings.md) · [Insiders](/companies/pntg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pntg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [140](/filings/0001766400-24-000128.md) | [146 d](/filings/0001766400-26-000014.md) | [157](/filings/0001766400-25-000069.md) | [169](/filings/0001766400-25-000103.md) | [181](/filings/0001766400-25-000139.md) | [189 d](/filings/0001766400-26-000014.md) | [210](/filings/0001766400-26-000054.md) | [220](/filings/0001766400-26-000065.md) | [229](/filings/0001766400-25-000139.md) | [289 d](/filings/0001766400-26-000014.md) | [285](/filings/0001766400-26-000054.md) | [298](/filings/0001766400-26-000065.md) |
| Selling, general and administrative | $m | [9.4](/filings/0001766400-24-000128.md) | [9.8 d](/filings/0001766400-26-000014.md) | [11.4](/filings/0001766400-25-000069.md) | [11.9](/filings/0001766400-25-000103.md) | [13.0](/filings/0001766400-25-000139.md) | [13.9 d](/filings/0001766400-26-000014.md) | [14.8](/filings/0001766400-26-000054.md) | [17.6](/filings/0001766400-26-000065.md) | [19.3](/filings/0001766400-25-000139.md) | [19.3 d](/filings/0001766400-26-000014.md) | [19.7](/filings/0001766400-26-000054.md) | [21.6](/filings/0001766400-26-000065.md) |
| Operating income | $m | [7.1](/filings/0001766400-24-000128.md) | [7.6 d](/filings/0001766400-26-000014.md) | [8.5](/filings/0001766400-25-000069.md) | [9.6](/filings/0001766400-25-000103.md) | [10.8](/filings/0001766400-25-000139.md) | [9.2 d](/filings/0001766400-26-000014.md) | [12.7](/filings/0001766400-26-000054.md) | [11.5](/filings/0001766400-26-000065.md) | [10.2](/filings/0001766400-25-000139.md) | [17.5 d](/filings/0001766400-26-000014.md) | [17.3](/filings/0001766400-26-000054.md) | [17.2](/filings/0001766400-26-000065.md) |
| Interest expense | $m | [1.5](/filings/0001766400-23-000127.md) | [1.6 d](/filings/0001766400-24-000022.md) | [1.8](/filings/0001766400-24-000056.md) | [1.6](/filings/0001766400-25-000103.md) | [2.9](/filings/0001766400-25-000139.md) | [0.7 d](/filings/0001766400-26-000014.md) | [1.2](/filings/0001766400-26-000054.md) | [1.2](/filings/0001766400-26-000065.md) | [1.0](/filings/0001766400-25-000139.md) | [3.3 d](/filings/0001766400-26-000014.md) | [3.1](/filings/0001766400-26-000054.md) | [3.3](/filings/0001766400-26-000065.md) |
| Income tax | $m | [1.1](/filings/0001766400-24-000128.md) | [1.8 d](/filings/0001766400-26-000014.md) | [1.8](/filings/0001766400-25-000069.md) | [1.8](/filings/0001766400-25-000103.md) | [1.4](/filings/0001766400-25-000139.md) | [2.1 d](/filings/0001766400-26-000014.md) | [2.9](/filings/0001766400-26-000054.md) | [2.6](/filings/0001766400-26-000065.md) | [2.5](/filings/0001766400-25-000139.md) | [3.9 d](/filings/0001766400-26-000014.md) | [3.8](/filings/0001766400-26-000054.md) | [3.9](/filings/0001766400-26-000065.md) |
| Net income | $m | [4.4](/filings/0001766400-24-000128.md) | [4.3 d](/filings/0001766400-26-000014.md) | [4.9](/filings/0001766400-25-000139.md) | [5.7](/filings/0001766400-25-000139.md) | [6.2](/filings/0001766400-25-000139.md) | [5.8 d](/filings/0001766400-26-000014.md) | [7.8](/filings/0001766400-26-000065.md) | [7.1](/filings/0001766400-26-000065.md) | [6.1](/filings/0001766400-25-000139.md) | [8.6 d](/filings/0001766400-26-000014.md) | [8.5](/filings/0001766400-26-000065.md) | [9.1](/filings/0001766400-26-000065.md) |
| Diluted EPS | $ per share | [0.15](/filings/0001766400-24-000128.md) | not reported | [0.16](/filings/0001766400-25-000069.md) | [0.18](/filings/0001766400-25-000103.md) | [0.20](/filings/0001766400-25-000139.md) | not reported | [0.22](/filings/0001766400-26-000054.md) | [0.20](/filings/0001766400-26-000065.md) | [0.17](/filings/0001766400-25-000139.md) | not reported | [0.24](/filings/0001766400-26-000054.md) | [0.25](/filings/0001766400-26-000065.md) |
| Basic EPS | $ per share | [0.15](/filings/0001766400-24-000128.md) | not reported | [0.16](/filings/0001766400-25-000069.md) | [0.19](/filings/0001766400-25-000103.md) | [0.20](/filings/0001766400-25-000139.md) | not reported | [0.23](/filings/0001766400-26-000054.md) | [0.21](/filings/0001766400-26-000065.md) | [0.18](/filings/0001766400-25-000139.md) | not reported | [0.25](/filings/0001766400-26-000054.md) | [0.26](/filings/0001766400-26-000065.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.4](/filings/0001766400-23-000127.md) | [6.1](/filings/0001766400-25-000024.md) | [2.7](/filings/0001766400-24-000056.md) | [3.0](/filings/0001766400-24-000096.md) | [4.5](/filings/0001766400-24-000128.md) | [24.2](/filings/0001766400-26-000014.md) | [5.2](/filings/0001766400-25-000069.md) | [14.4](/filings/0001766400-25-000103.md) | [2.3](/filings/0001766400-25-000139.md) | [17.0](/filings/0001766400-26-000065.md) | [4.9](/filings/0001766400-26-000054.md) | [15.3](/filings/0001766400-26-000065.md) |
| Current assets | $m | [72.2](/filings/0001766400-23-000127.md) | [80.1](/filings/0001766400-25-000024.md) | [87.1](/filings/0001766400-24-000056.md) | [94.1](/filings/0001766400-24-000096.md) | [102](/filings/0001766400-24-000128.md) | [123](/filings/0001766400-26-000014.md) | [124](/filings/0001766400-25-000069.md) | [127](/filings/0001766400-25-000103.md) | [114](/filings/0001766400-25-000139.md) | [167](/filings/0001766400-26-000065.md) | [153](/filings/0001766400-26-000054.md) | [184](/filings/0001766400-26-000065.md) |
| Total assets | $m | [520](/filings/0001766400-23-000127.md) | [540](/filings/0001766400-25-000024.md) | [578](/filings/0001766400-24-000056.md) | [602](/filings/0001766400-24-000096.md) | [647](/filings/0001766400-24-000128.md) | [680](/filings/0001766400-26-000014.md) | [744](/filings/0001766400-25-000069.md) | [751](/filings/0001766400-25-000103.md) | [754](/filings/0001766400-25-000139.md) | [968](/filings/0001766400-26-000065.md) | [956](/filings/0001766400-26-000054.md) | [1,037](/filings/0001766400-26-000065.md) |
| Current liabilities | $m | [68.8](/filings/0001766400-23-000127.md) | [71.5](/filings/0001766400-25-000024.md) | [75.2](/filings/0001766400-24-000056.md) | [83.7](/filings/0001766400-24-000096.md) | [90.6](/filings/0001766400-24-000128.md) | [102](/filings/0001766400-26-000014.md) | [88.0](/filings/0001766400-25-000069.md) | [105](/filings/0001766400-25-000103.md) | [109](/filings/0001766400-25-000139.md) | [147](/filings/0001766400-26-000065.md) | [129](/filings/0001766400-26-000054.md) | [152](/filings/0001766400-26-000065.md) |
| Total liabilities | $m | [381](/filings/0001766400-23-000127.md) | [394](/filings/0001766400-25-000024.md) | [414](/filings/0001766400-24-000056.md) | [429](/filings/0001766400-24-000096.md) | [459](/filings/0001766400-24-000128.md) | [368](/filings/0001766400-26-000014.md) | [421](/filings/0001766400-25-000069.md) | [418](/filings/0001766400-25-000103.md) | [411](/filings/0001766400-25-000139.md) | [594](/filings/0001766400-26-000065.md) | [567](/filings/0001766400-26-000054.md) | [633](/filings/0001766400-26-000065.md) |
| Long-term debt | $m | [53.8](/filings/0001766400-23-000127.md) | [63.9](/filings/0001766400-25-000024.md) | [83.3](/filings/0001766400-24-000056.md) | [82.2](/filings/0001766400-24-000096.md) | [109](/filings/0001766400-24-000128.md) | [0.0](/filings/0001766400-26-000014.md) | [52.5](/filings/0001766400-25-000069.md) | [37.0](/filings/0001766400-25-000103.md) | [26.0](/filings/0001766400-25-000139.md) | [169](/filings/0001766400-26-000065.md) | [165](/filings/0001766400-26-000054.md) | [192](/filings/0001766400-26-000065.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001766400-26-000014.md) | not reported | not reported | not reported | [5.0](/filings/0001766400-26-000065.md) | [5.0](/filings/0001766400-26-000054.md) | [5.0](/filings/0001766400-26-000065.md) |
| Shareholders' equity | $m | [140](/filings/0001766400-24-000128.md) | [146](/filings/0001766400-26-000014.md) | [164](/filings/0001766400-25-000139.md) | [173](/filings/0001766400-25-000139.md) | [187](/filings/0001766400-25-000139.md) | [312](/filings/0001766400-26-000065.md) | [323](/filings/0001766400-26-000065.md) | [334](/filings/0001766400-26-000065.md) | [343](/filings/0001766400-25-000139.md) | [374](/filings/0001766400-26-000065.md) | [389](/filings/0001766400-26-000065.md) | [404](/filings/0001766400-26-000065.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.4 d](/filings/0001766400-24-000128.md) | [5.2 d](/filings/0001766400-26-000014.md) | [0.5](/filings/0001766400-25-000069.md) | [10.5 d](/filings/0001766400-25-000103.md) | [7.7 d](/filings/0001766400-25-000139.md) | [20.6 d](/filings/0001766400-26-000014.md) | [(21.2)](/filings/0001766400-26-000054.md) | [34.6 d](/filings/0001766400-26-000065.md) | [13.9 d](/filings/0001766400-25-000139.md) | [21.0 d](/filings/0001766400-26-000014.md) | [(3.4)](/filings/0001766400-26-000054.md) | [21.8 d](/filings/0001766400-26-000065.md) |
| Capital expenditure | $m | [1.8 d](/filings/0001766400-24-000128.md) | [2.4 d](/filings/0001766400-26-000014.md) | [3.1](/filings/0001766400-25-000069.md) | [1.6 d](/filings/0001766400-25-000103.md) | [0.9 d](/filings/0001766400-25-000139.md) | [3.3 d](/filings/0001766400-26-000014.md) | [2.0](/filings/0001766400-26-000054.md) | [3.1 d](/filings/0001766400-26-000065.md) | [3.5 d](/filings/0001766400-25-000139.md) | [3.6 d](/filings/0001766400-26-000014.md) | [5.3](/filings/0001766400-26-000054.md) | [6.3 d](/filings/0001766400-26-000065.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [30.2](/filings/0001766400-23-000127.md) | [30.1](/filings/0001766400-24-000056.md) | [30.2](/filings/0001766400-24-000096.md) | [30.2](/filings/0001766400-24-000128.md) | [30.4](/filings/0001766400-25-000069.md) | [30.8](/filings/0001766400-25-000103.md) | [31.4](/filings/0001766400-25-000139.md) | [35.2](/filings/0001766400-26-000054.md) | [35.4](/filings/0001766400-26-000065.md) | [35.3](/filings/0001766400-25-000139.md) | [35.8](/filings/0001766400-26-000054.md) | [36.0](/filings/0001766400-26-000065.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 34,929,074 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0001766400-26-000065.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.